List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 25 studies with search of: GlaxoSmithKline, PROMACTA
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Eltrombopag and the Bcl-xL Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Promacta (eltrombopag)
2 Recruiting EXTEND (Eltrombopag Extended Dosing Study)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag olamine (SB-497115-GR)
3 Completed
Has Results 		Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Interventions: Drug: SB-497115-GR 12.5mg tablet;   Drug: SB-497115-GR 25mg tablet;   Drug: SB-497115-GR 12.5mg matching placebo tablet
4 Not yet recruiting Milk-only Lactation Study for Patients on Eltrombopag
Condition: Thrombocytopaenia
Intervention: Drug: eltrombopag
5 Active, not recruiting Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Eltrombopag oral tablets
6 Active, not recruiting Promacta Pregnancy Registry
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Eltrombopag
7 Recruiting Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
Condition: Healthy Subjects
Interventions: Drug: Ciprofloxacin;   Drug: Eltrombopag
8 Completed Eltrombopag Taste Testing in Healthy Adult Volunteers
Condition: Healthy Subjects
Intervention: Drug: eltrombopag
9 Active, not recruiting Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
Condition: Thrombocytopenia
Interventions: Drug: eltrombopag 25mg tablet;   Drug: eltrombopag 12.5mg tablet
10 Completed
Has Results 		Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag
11 Terminated Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Conditions: Thrombocytopenia;   Chronic Liver Disease;   Hepatitis C Virus;   HCV;   Hepatitis B Virus;   HBV;   Human Immunodeficiency Virus;   HIV Infection;   Non-alcoholic Steatohepatitis;   NASH.
Interventions: Drug: Placebo;   Drug: Eltrombopag
12 Recruiting Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Conditions: Advanced Myelodysplastic Syndrome;   Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia After MDS;   Thrombocytopenia
Interventions: Drug: eltrombopag olamine;   Other: Placebo
13 Recruiting LENS - Long-term Eltrombopag Observational Study
Condition: Ocular Safety
Intervention: Drug: Observational Study
14 Not yet recruiting Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
Condition: Thrombocytopenia
Interventions: Drug: Eltrombopag and Lopinavir/Ritonavir;   Drug: Lopinavir/Ritonavir;   Drug: Eltrombopag
15 Recruiting Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic ITP
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: eltrombopag;   Drug: Placebo
16 Recruiting Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
Conditions: Sarcoma;   Thrombocytopenia;   Thrombopoiesis
Intervention: Drug: eltrombopag
17 Completed RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag
18 Active, not recruiting Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease
Conditions: Thrombocytopenia;   Hepatitis C
Intervention: Drug: eltrombopag
19 Active, not recruiting Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
Conditions: Thrombocytopenia;   Hepatitis C
Intervention: Drug: eltrombopag
20 Completed Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
Condition: Hepatic Impairment
Intervention: Drug: eltrombopag

Previous Page Studies Shown (1-20) Next Page (21-25)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services